博时恒生医疗保健(QDII-ETF)(513060) |
净值:
0.4498
|
日增长率:
-0.07%
|
累计净值:0.4498 | 2025-04-18 |
|
股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
06160 | 百济神州 | 12,942,000.00 | 1,308,741,217.05 | 9.21 |
02269 | 药明生物 | 74,166,500.00 | 1,206,040,917.79 | 8.48 |
01801 | 信达生物 | 29,120,000.00 | 986,966,023.68 | 6.94 |
09926 | 康方生物 | 12,882,000.00 | 724,105,309.90 | 5.10 |
01093 | 石药集团 | 163,100,000.00 | 721,957,452.72 | 5.08 |
01177 | 中国生物制药 | 205,021,000.00 | 607,544,469.89 | 4.27 |
06618 | 京东健康 | 22,151,600.00 | 576,422,821.36 | 4.06 |
01099 | 国药控股 | 26,617,600.00 | 525,022,897.07 | 3.69 |
06160 | 百济神州 | 5,001,800.00 | 505,799,862.42 | 3.56 |
01093 | 石药集团 | 107,222,000.00 | 474,615,095.01 | 3.34 |
09926 | 康方生物 | 8,165,000.00 | 458,959,777.62 | 3.23 |
02367 | 巨子生物 | 9,178,600.00 | 424,137,562.13 | 2.98 |
00241 | 阿里健康 | 127,686,000.00 | 392,564,580.22 | 2.76 |
06618 | 京东健康 | 14,083,200.00 | 366,469,143.44 | 2.58 |
01099 | 国药控股 | 18,160,400.00 | 358,207,570.18 | 2.52 |
01801 | 信达生物 | 9,532,000.00 | 323,068,686.05 | 2.27 |
02269 | 药明生物 | 19,339,000.00 | 314,476,553.55 | 2.21 |
00241 | 阿里健康 | 90,724,000.00 | 278,926,655.83 | 1.96 |
01177 | 中国生物制药 | 74,981,000.00 | 222,193,296.77 | 1.56 |
02367 | 巨子生物 | 3,765,600.00 | 174,006,101.58 | 1.22 |
行业名称 | 持仓市值(元) | 占基金净值比(%) | 占股票市值比(%) |
医疗保健 | 12,506,697,405.20 | 87.98 | 88.74 |
日常消费品 | 1,501,411,238.12 | 10.56 | 10.65 |
金融 | 86,174,541.32 | 0.61 | 0.61 |
报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
2024-12-31 | 99.14 | - | 2.37 | 14,215,891,386.83 |
2024-09-30 | 99.46 | - | 0.53 | 13,157,802,156.15 |
2024-06-30 | 99.16 | - | 0.37 | 10,249,996,702.16 |
2024-03-31 | 99.61 | - | 0.67 | 10,514,403,354.54 |
2023-12-31 | 99.64 | - | 0.86 | 13,329,826,676.59 |